(Bloomberg) -- London-based asset manager Ashmore Group PLC is reducing its exposure to Indian equities and has made China the #1 pick in its emerging-markets fund, arguing that India’s stock market is overhyped and overcrowded while China’s is set for a rebound. Most Read from Bloomberg Dubai Grinds to Standstill as Cloud Seeding Worsens Flooding What If Fed Rate Hikes Are Actually Sparking US Economic Boom? China Tells Iran Cooperation Will Last After Attack on Israel Powell Signals Rate-Cut Delay After Run of Inflation Surprises US Yields Spike as Hawkish Powell Puts 5% in Play: Markets Wrap With $6.5 billion invested in emerging equities, the fund has allocated 26% of its EM equity fund to China, while reducing India to less than half that, according to Edward Evans, a London-based EM equities portfolio manager. He cites a divergence in valuations as the main reason for the decision. “The risk-reward balance is arguably stronger for China and less so for India,” Evans said. “India demonstrates fantastic economic growth with great policy stability and it’s often quite a fertile ground for stock selection. But that said, one cannot be agnostic to price, not least in fast-growing emerging markets, since you do not want to pay up front for those future returns.” Ashmore’s bet goes against market consensus. Almost half of 390 Bloomberg MLIV Pulse survey respondents between April 8-12 selected India as the best investment compared to Japan and China, which was least favored among the three. Indian equities currently trade at a whopping 23 times next year’s expected earnings, exceeding even US multiples, and compared with nine for China, according to data compiled by Bloomberg based on MSCI Inc.’s indexes. Read: Overpriced India Lures Investors Tired of China Risk: MLIV Pulse Ashmore has also previously been overweight India, but has booked profits as many companies reached valuations at “extremes” that “ultimately don’t look sustainable,” Evans said. “We are a quality-growth investor, but we are not agnostic to valuation, or to price, and that led us to take profits.” He also cited a risk in India that authorities could look to dampen more speculative investing behavior, especially in the domestic market, making the policy narrative less supportive. In China, the risks are well known, ranging from geopolitical tensions and a trade showdown with the US, to a property sector crisis and growth that’s cooling from the world-beating levels the economy enjoyed over past decades. The main gauge of Chinese equities has tumbled about 40% from its peak three years ago, and is down 19% in the past year, compared with a 33% gain for the benchmark MSCI India index. China’s economic growth is expected to trail India’s for at least the next two years, according to economists’ forecasts on Bloomberg. Still, Evans sees tentative signs of recovery in China, including pickups in factory activity and exports. He points to Caixin manufacturing PMI data, which indicated a fifth straight month of expansion in March, with official government data also showing a rebound. Exports have also increased amid rising global demand for technology goods. Read: Goldman, Morgan Stanley Boost China’s 2024 Growth Outlook Evans said Chinese companies’ shares will also benefit from tight cost management, share buybacks and increasing dividends. Those measures are putting a floor under valuations and offer “a rich potential and a shining opportunity,” he said. Companies in industries such as the supply chain behind AI and electric-vehicle renewables are likely to be drivers of future performance, he said. The balance sheet for the Chinese consumer is still strong and there’s also opportunity in consumer-focused shares, especially in services, he said. Ashmore’s pure EM equity fund has gained 5% on average annually over the past five years, a paltry return compared with that enjoyed by investors in US stocks, but still double the average return of peers in emerging markets. The fund has performed in parallel with the average so far in 2024, according to data compiled by Bloomberg. --With assistance from Srinivasan Sivabalan. Most Read from Bloomberg Businessweek A Very Bad Week for Tesla, Its Employees and Even Elon Musk For Multinationals, Africa’s Allure Is Fading A Resilient Global Economy Masks Growing Debt and Inequality Cities Use AI to Help Ambulances and Firetrucks Arrive Faster The Shadow Swiftie Economy Booms With Bootleg Bracelets and $1,150 Bodysuits ©2024 Bloomberg L.P.
Ashmore Counters Consensus With Big Bet on China Over India
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...